impicciarsi Intarsio Metodo paclitaxel clinical trials reggiseno letale Cena
Paclitaxel and Carboplatin for Carcinoma Clinical Trial | Power
Paclitaxel nanoformulations that are approved or in clinical trials for... | Download Scientific Diagram
Study schematics of ongoing Phase iii trials of atezolizumab in... | Download Scientific Diagram
HER2 and Response to Paclitaxel in Node-Positive Breast Cancer | NEJM
Open-label randomized clinical trial of standard neoadjuvant chemotherapy with paclitaxel followed by FEC versus the combination of paclitaxel and everolimus followed by FEC in women with triple receptor-negative breast cancer† - Annals
Efficacy and safety of first-line veliparib and carboplatin–paclitaxel in patients with HER2− advanced germline BRCA+ breast cancer: Subgroup analysis of a randomised clinical trial - European Journal of Cancer
CIRSE 2019: Hear the latest from clinical trials comparing paclitaxel technologies head-to-head - Vascular News
Efficacy and safety of a novel paclitaxel-nano-coated balloon for femoropopliteal angioplasty: one-year results of the EffPac trial - EuroIntervention
Paclitaxel (Taxol) in breast cancer adjuvant therapy: chronology of... | Download Scientific Diagram
Clinical Trials Included in the Meta-Analysis | Download Table
Paclitaxel nanoformulations that are approved or in clinical trials for... | Download Scientific Diagram
CLINICAL TRIALS [GANNET53]
Pembrolizumab versus paclitaxel for previously treated, advanced gastric or gastro-oesophageal junction cancer (KEYNOTE-061): a randomised, open-label, controlled, phase 3 trial - The Lancet
Phase 3 Trial Comparing Nanoparticle Albumin-Bound Paclitaxel With Docetaxel for Previously Treated Advanced NSCLC - ScienceDirect
Flow chart of study population of the PICCOLETO trial. PCB,... | Download Scientific Diagram
Paclitaxel Poliglumex - an overview | ScienceDirect Topics
PLOS ONE: A First-Time-In-Human Phase I Clinical Trial of Bispecific Antibody-Targeted, Paclitaxel-Packaged Bacterial Minicells
Improvement of Paclitaxel-Associated Adverse Reactions (ADRs) via the | IJN
Assessment of an RNA interference screen-derived mitotic and ceramide pathway metagene as a predictor of response to neoadjuvant paclitaxel for primary triple-negative breast cancer: a retrospective analysis of five clinical trials -
A randomized phase III trial in patients with recurrent platinum sensitive ovarian cancer comparing efficacy and safety of paclitaxel micellar and Cremophor EL-paclitaxel - Gynecologic Oncology
cisplatin and nab-paclitaxel for Biliary Tract Cancer Clinical Trial | Power